Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. F Stephen Hodi, Marcus Butler, +17 authors, Darryl A Oble, Michael V Seiden, Frank G Haluska, Andrea Kruse, Suzanne Macrae, Marybeth Nelson, Christine Canning, Israel Lowy, Alan Korman, David Lautz, Sara Russell, Michael T Jaklitsch, Nikhil Ramaiya, Teresa C Chen, Donna Neuberg, James P Allison, Martin C Mihm, Glenn Dranoff. less Proc Natl Acad Sci U S A, 2008 Feb 22; 105(8). PMID: 18287062 Free PMC article. Highly Cited.
|
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. L Chen, S Ashe, +5 authors, W A Brady, I Hellström, K E Hellström, J A Ledbetter, P McGowan, P S Linsley. less Cell, 1992 Dec 24; 71(7). PMID: 1335364 Highly Cited.
|
Restoring function in exhausted CD8 T cells during chronic viral infection. Daniel L Barber, E John Wherry, +5 authors, David Masopust, Baogong Zhu, James P Allison, Arlene H Sharpe, Gordon J Freeman, Rafi Ahmed. less Nature, 2005 Dec 31; 439(7077). PMID: 16382236 Highly Cited.
|
Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}. Mark P Rubinstein, Marek Kovar, +4 authors, Jared F Purton, Jae-Ho Cho, Onur Boyman, Charles D Surh, Jonathan Sprent. less Proc Natl Acad Sci U S A, 2006 Jun 08; 103(24). PMID: 16757567 Free PMC article. Highly Cited.
|
In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB). De-Gang Song, Qunrui Ye, +7 authors, Carmine Carpenito, Mathilde Poussin, Li-Ping Wang, Chunyan Ji, Mariangela Figini, Carl H June, George Coukos, Daniel J Powell. less Cancer Res, 2011 May 07; 71(13). PMID: 21546571 Free PMC article. Highly Cited.
|
IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. Ilaria Peluso, Massimo Claudio Fantini, +5 authors, Daniele Fina, Roberta Caruso, Monica Boirivant, Thomas T MacDonald, Francesco Pallone, Giovanni Monteleone. less J Immunol, 2007 Jan 05; 178(2). PMID: 17202333
|
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. Luca Gattinoni, Steven E Finkelstein, +10 authors, Christopher A Klebanoff, Paul A Antony, Douglas C Palmer, Paul J Spiess, Leroy N Hwang, Zhiya Yu, Claudia Wrzesinski, David M Heimann, Charles D Surh, Steven A Rosenberg, Nicholas P Restifo. less J Exp Med, 2005 Oct 06; 202(7). PMID: 16203864 Free PMC article. Highly Cited.
|
Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. R J North. J Exp Med, 1982 Apr 01; 155(4). PMID: 6460831 Free PMC article. Highly Cited.
|
Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Antoni Ribas, Begoña Comin-Anduix, +15 authors, Bartosz Chmielowski, Jason Jalil, Pilar de la Rocha, Tara A McCannel, Maria Teresa Ochoa, Elizabeth Seja, Arturo Villanueva, Denise K Oseguera, Bradley R Straatsma, Alistair J Cochran, John A Glaspy, Liu Hui, Francesco M Marincola, Ena Wang, James S Economou, Jesus Gomez-Navarro. less Clin Cancer Res, 2009 Oct 01; 15(19). PMID: 19789309 Free PMC article.
|
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. Ganesh Suntharalingam, Meghan R Perry, +4 authors, Stephen Ward, Stephen J Brett, Andrew Castello-Cortes, Michael D Brunner, Nicki Panoskaltsis. less N Engl J Med, 2006 Aug 16; 355(10). PMID: 16908486 Highly Cited.
|
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Mark E Dudley, John R Wunderlich, +16 authors, Paul F Robbins, James C Yang, Patrick Hwu, Douglas J Schwartzentruber, Suzanne L Topalian, Richard Sherry, Nicholas P Restifo, Amy M Hubicki, Michael R Robinson, Mark Raffeld, Paul Duray, Claudia A Seipp, Linda Rogers-Freezer, Kathleen E Morton, Sharon A Mavroukakis, Donald E White, Steven A Rosenberg. less Science, 2002 Sep 21; 298(5594). PMID: 12242449 Free PMC article. Highly Cited.
|
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. Mark E Dudley, John R Wunderlich, +18 authors, James C Yang, Richard M Sherry, Suzanne L Topalian, Nicholas P Restifo, Richard E Royal, Udai Kammula, Don E White, Sharon A Mavroukakis, Linda J Rogers, Gerald J Gracia, Stephanie A Jones, David P Mangiameli, Michelle M Pelletier, Juan Gea-Banacloche, Michael R Robinson, David M Berman, Armando C Filie, Andrea Abati, Steven A Rosenberg. less J Clin Oncol, 2005 Apr 01; 23(10). PMID: 15800326 Free PMC article. Highly Cited.
|
A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia. Richard R Furman, Andres Forero-Torres, Andrei Shustov, Jonathan G Drachman. Leuk Lymphoma, 2009 Dec 30; 51(2). PMID: 20038235
|
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Catherine A Sabatos, Sumone Chakravarti, +7 authors, Eugene Cha, Anna Schubart, Alberto Sánchez-Fueyo, Xin Xiao Zheng, Anthony J Coyle, Terry B Strom, Gordon J Freeman, Vijay K Kuchroo. less Nat Immunol, 2003 Oct 14; 4(11). PMID: 14556006 Highly Cited.
|
Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer. Yana G Najjar, James H Finke. Front Oncol, 2013 Mar 20; 3. PMID: 23508517 Free PMC article.
|
Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma. Lihua E Budde, Carolina Berger, +9 authors, Yukang Lin, Jinjuan Wang, Xubin Lin, Shani E Frayo, Shaunda A Brouns, David M Spencer, Brian G Till, Michael C Jensen, Stanley R Riddell, Oliver W Press. less PLoS One, 2013 Dec 21; 8(12). PMID: 24358223 Free PMC article. Highly Cited.
|
Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells. Shin-Young Na, Andreas Hermann, +3 authors, Monica Sanchez-Ruiz, Alexander Storch, Martina Deckert, Thomas Hünig. less Immunity, 2012 Jun 12; 37(1). PMID: 22683122
|
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. Julie R Brahmer, Scott S Tykodi, +23 authors, Laura Q M Chow, Wen-Jen Hwu, Suzanne L Topalian, Patrick Hwu, Charles G Drake, Luis H Camacho, John Kauh, Kunle Odunsi, Henry C Pitot, Omid Hamid, Shailender Bhatia, Renato Martins, Keith Eaton, Shuming Chen, Theresa M Salay, Suresh Alaparthy, Joseph F Grosso, Alan J Korman, Susan M Parker, Shruti Agrawal, Stacie M Goldberg, Drew M Pardoll, Ashok Gupta, Jon M Wigginton. less N Engl J Med, 2012 Jun 05; 366(26). PMID: 22658128 Free PMC article. Highly Cited.
|
Dendritic cells and the control of immunity. J Banchereau, R M Steinman. Nature, 1998 Apr 01; 392(6673). PMID: 9521319 Highly Cited. Review.
|
Cancer immunotherapy via dendritic cells. Karolina Palucka, Jacques Banchereau. Nat Rev Cancer, 2012 Mar 23; 12(4). PMID: 22437871 Free PMC article. Highly Cited. Review.
|
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. Paul F Robbins, Richard A Morgan, +18 authors, Steven A Feldman, James C Yang, Richard M Sherry, Mark E Dudley, John R Wunderlich, Azam V Nahvi, Lee J Helman, Crystal L Mackall, Udai S Kammula, Marybeth S Hughes, Nicholas P Restifo, Mark Raffeld, Chyi-Chia Richard Lee, Catherine L Levy, Yong F Li, Mona El-Gamil, Susan L Schwarz, Carolyn Laurencot, Steven A Rosenberg. less J Clin Oncol, 2011 Feb 02; 29(7). PMID: 21282551 Free PMC article. Highly Cited.
|
Improved survival with ipilimumab in patients with metastatic melanoma. F Stephen Hodi, Steven J O'Day, +26 authors, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel, Wallace Akerley, Alfons J M van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia M Vaubel, Gerald P Linette, David Hogg, Christian H Ottensmeier, Celeste Lebbé, Christian Peschel, Ian Quirt, Joseph I Clark, Jedd D Wolchok, Jeffrey S Weber, Jason Tian, Michael J Yellin, Geoffrey M Nichol, Axel Hoos, Walter J Urba. less N Engl J Med, 2010 Jun 08; 363(8). PMID: 20525992 Free PMC article. Highly Cited.
|
CAR T cells: driving the road from the laboratory to the clinic. Eleanor J Cheadle, Hannah Gornall, +3 authors, Vania Baldan, Vivien Hanson, Robert E Hawkins, David E Gilham. less Immunol Rev, 2013 Dec 18; 257(1). PMID: 24329792 Review.
|
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. L Diehl, A T den Boer, +5 authors, S P Schoenberger, E I van der Voort, T N Schumacher, C J Melief, R Offringa, R E Toes. less Nat Med, 1999 Jul 08; 5(7). PMID: 10395322 Highly Cited.
|
Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Thomas R Malek, Iris Castro. Immunity, 2010 Aug 25; 33(2). PMID: 20732639 Free PMC article. Highly Cited. Review.
|
CD40 ligation reverses T cell tolerance in acute myeloid leukemia. Long Zhang, Xiufen Chen, +4 authors, Xiao Liu, Douglas E Kline, Ryan M Teague, Thomas F Gajewski, Justin Kline. less J Clin Invest, 2013 Apr 27; 123(5). PMID: 23619361 Free PMC article.
|
A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma. Mohamad Hussein, James R Berenson, +6 authors, Ruben Niesvizky, Nikhil Munshi, Jeffrey Matous, Ronald Sobecks, Kate Harrop, Jonathan G Drachman, Nancy Whiting. less Haematologica, 2010 Feb 06; 95(5). PMID: 20133895 Free PMC article.
|
First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting. Andrea Molckovsky, Lillian L Siu. J Hematol Oncol, 2008 Oct 31; 1. PMID: 18959794 Free PMC article.
|
The promise and potential pitfalls of chimeric antigen receptors. Michel Sadelain, Renier Brentjens, Isabelle Rivière. Curr Opin Immunol, 2009 Mar 31; 21(2). PMID: 19327974 Free PMC article. Highly Cited. Review.
|
Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2. T J Eberlein, M Rosenstein, S A Rosenberg. J Exp Med, 1982 Aug 01; 156(2). PMID: 6980254 Free PMC article. Highly Cited.
|
OX40 costimulation turns off Foxp3+ Tregs. Minh Diem Vu, Xiang Xiao, +6 authors, Wenda Gao, Nicolas Degauque, Ming Chen, Alexander Kroemer, Nigel Killeen, Naoto Ishii, Xian Chang Li. less Blood, 2007 Jun 19; 110(7). PMID: 17575071 Free PMC article. Highly Cited.
|
Peripheral tolerance of CD8 T lymphocytes. William L Redmond, Linda A Sherman. Immunity, 2005 Mar 23; 22(3). PMID: 15780985 Review.
|
Adoptive immunotherapy for cancer: harnessing the T cell response. Nicholas P Restifo, Mark E Dudley, Steven A Rosenberg. Nat Rev Immunol, 2012 Mar 23; 12(4). PMID: 22437939 Free PMC article. Highly Cited. Review.
|
Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor. S Mallett, S Fossum, A N Barclay. EMBO J, 1990 Apr 01; 9(4). PMID: 2157591 Free PMC article. Highly Cited.
|
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. David Saadoun, Michelle Rosenzwajg, +6 authors, Florence Joly, Adrien Six, Fabrice Carrat, Vincent Thibault, Damien Sene, Patrice Cacoub, David Klatzmann. less N Engl J Med, 2011 Dec 02; 365(22). PMID: 22129253 Highly Cited.
|
II. Contribution to the Knowledge of Sarcoma. W B Coley. Ann Surg, 1891 Sep 01; 14(3). PMID: 17859590 Free PMC article. Highly Cited.
|
Role of LAG-3 in regulatory T cells. Ching-Tai Huang, Creg J Workman, +11 authors, Dallas Flies, Xiaoyu Pan, Aimee L Marson, Gang Zhou, Edward L Hipkiss, Sowmya Ravi, Jeanne Kowalski, Hyam I Levitsky, Jonathan D Powell, Drew M Pardoll, Charles G Drake, Dario A A Vignali. less Immunity, 2004 Oct 16; 21(4). PMID: 15485628 Highly Cited.
|
Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. Louise E Clough, Chun Jing Wang, +4 authors, Emily M Schmidt, George Booth, Tie Zheng Hou, Gemma A Ryan, Lucy S K Walker. less J Immunol, 2008 Apr 09; 180(8). PMID: 18390721
|
Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients. Joannes F M Jacobs, Cornelis J A Punt, +8 authors, W Joost Lesterhuis, Roger P M Sutmuller, H Mary-Lène H Brouwer, Nicole M Scharenborg, Ina S Klasen, Luuk B Hilbrands, Carl G Figdor, I Jolanda M de Vries, Gosse J Adema. less Clin Cancer Res, 2010 Aug 26; 16(20). PMID: 20736326
|
Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Steven A Rosenberg, Nicholas P Restifo, +2 authors, James C Yang, Richard A Morgan, Mark E Dudley. less Nat Rev Cancer, 2008 Mar 21; 8(4). PMID: 18354418 Free PMC article. Highly Cited. Review.
|
Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Nikolaos Patsoukis, Julia Brown, +3 authors, Victoria Petkova, Fang Liu, Lequn Li, Vassiliki A Boussiotis. less Sci Signal, 2012 Jun 29; 5(230). PMID: 22740686 Free PMC article. Highly Cited.
|
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. Suzanne L Topalian, F Stephen Hodi, +27 authors, Julie R Brahmer, Scott N Gettinger, David C Smith, David F McDermott, John D Powderly, Richard D Carvajal, Jeffrey A Sosman, Michael B Atkins, Philip D Leming, David R Spigel, Scott J Antonia, Leora Horn, Charles G Drake, Drew M Pardoll, Lieping Chen, William H Sharfman, Robert A Anders, Janis M Taube, Tracee L McMiller, Haiying Xu, Alan J Korman, Maria Jure-Kunkel, Shruti Agrawal, Daniel McDonald, Georgia D Kollia, Ashok Gupta, Jon M Wigginton, Mario Sznol. less N Engl J Med, 2012 Jun 05; 366(26). PMID: 22658127 Free PMC article. Highly Cited.
|
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Michael A Curran, Welby Montalvo, Hideo Yagita, James P Allison. Proc Natl Acad Sci U S A, 2010 Feb 18; 107(9). PMID: 20160101 Free PMC article. Highly Cited.
|
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. Jens Dannull, Zhen Su, +8 authors, David Rizzieri, Benjamin K Yang, Doris Coleman, Donna Yancey, Aijing Zhang, Philipp Dahm, Nelson Chao, Eli Gilboa, Johannes Vieweg. less J Clin Invest, 2005 Nov 26; 115(12). PMID: 16308572 Free PMC article. Highly Cited.
|
Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignancies. Mayer N Fishman, John A Thompson, +8 authors, Gregory K Pennock, Rene Gonzalez, Luz M Diez, Adil I Daud, Jeffery S Weber, Bee Y Huang, Shamay Tang, Peter R Rhode, Hing C Wong. less Clin Cancer Res, 2011 Oct 14; 17(24). PMID: 21994418 Free PMC article.
|
A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma. William Bensinger, Richard T Maziarz, +8 authors, Sundar Jagannath, Andrew Spencer, Simon Durrant, Pamela S Becker, Brett Ewald, Sanela Bilic, John Rediske, Johan Baeck, Edward A Stadtmauer. less Br J Haematol, 2012 Aug 07; 159(1). PMID: 22861192
|
IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes. Yongqing Li, Cassian Yee. Blood, 2007 Oct 09; 111(1). PMID: 17921346 Free PMC article.
|
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Jason D Fontenot, Marc A Gavin, Alexander Y Rudensky. Nat Immunol, 2003 Mar 04; 4(4). PMID: 12612578 Highly Cited.
|
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Richard A Morgan, James C Yang, +3 authors, Mio Kitano, Mark E Dudley, Carolyn M Laurencot, Steven A Rosenberg. less Mol Ther, 2010 Feb 25; 18(4). PMID: 20179677 Free PMC article. Highly Cited.
|
Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state. Andrea Schietinger, Jeffrey J Delrow, +2 authors, Ryan S Basom, Joseph N Blattman, Philip D Greenberg. less Science, 2012 Jan 24; 335(6069). PMID: 22267581 Free PMC article. Highly Cited.
|
Systemic administration of interleukin-2 in humans. M T Lotze, R J Robb, +2 authors, S O Sharrow, L W Frana, S A Rosenberg. less J Biol Response Mod, 1984 Oct 01; 3(5). PMID: 6334135
|
The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Jacques Banchereau, LuAnn Thompson-Snipes, +6 authors, Sandra Zurawski, Jean-Philippe Blanck, Yanying Cao, Sandra Clayton, Jean-Pierre Gorvel, Gerard Zurawski, Eynav Klechevsky. less Blood, 2012 Apr 27; 119(24). PMID: 22535664 Free PMC article.
|
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Thomas A Waldmann. Nat Rev Immunol, 2006 Jul 27; 6(8). PMID: 16868550 Highly Cited. Review.
|
Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. B K Cho, V P Rao, +2 authors, Q Ge, H N Eisen, J Chen. less J Exp Med, 2000 Aug 22; 192(4). PMID: 10952724 Free PMC article. Highly Cited.
|
Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells. Andrew J Rech, Robert H Vonderheide. Ann N Y Acad Sci, 2009 Sep 23; 1174. PMID: 19769742 Highly Cited. Review.
|
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. P Waterhouse, J M Penninger, +6 authors, E Timms, A Wakeham, A Shahinian, K P Lee, C B Thompson, H Griesser, T W Mak. less Science, 1995 Nov 10; 270(5238). PMID: 7481803 Highly Cited.
|
Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. Srinivas Nagaraj, Adam G Schrum, +2 authors, Hyun-Il Cho, Esteban Celis, Dmitry I Gabrilovich. less J Immunol, 2010 Feb 10; 184(6). PMID: 20142361 Free PMC article. Highly Cited.
|
In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. Laura C Bonifaz, David P Bonnyay, +7 authors, Anna Charalambous, Dara I Darguste, Shin-Ichiro Fujii, Helena Soares, Marie K Brimnes, Bruno Moltedo, Thomas M Moran, Ralph M Steinman. less J Exp Med, 2004 Mar 17; 199(6). PMID: 15024047 Free PMC article. Highly Cited.
|
Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. W R Godfrey, F F Fagnoni, +2 authors, M A Harara, D Buck, E G Engleman. less J Exp Med, 1994 Aug 01; 180(2). PMID: 7913952 Free PMC article.
|
Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. I Gramaglia, A D Weinberg, M Lemon, M Croft. J Immunol, 1998 Dec 23; 161(12). PMID: 9862675 Highly Cited.
|
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. C Marcela Diaz-Montero, Mohamed Labib Salem, +3 authors, Michael I Nishimura, Elizabeth Garrett-Mayer, David J Cole, Alberto J Montero. less Cancer Immunol Immunother, 2008 May 01; 58(1). PMID: 18446337 Free PMC article. Highly Cited.
|
Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. L A Schubert, E Jeffery, +2 authors, Y Zhang, F Ramsdell, S F Ziegler. less J Biol Chem, 2001 Aug 03; 276(40). PMID: 11483607 Highly Cited.
|
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. S Read, V Malmström, F Powrie. J Exp Med, 2000 Jul 19; 192(2). PMID: 10899916 Free PMC article. Highly Cited.
|
Durable adoptive immunotherapy for leukemia produced by manipulation of multiple regulatory pathways of CD8+ T-cell tolerance. Melissa M Berrien-Elliott, Stephanie R Jackson, +6 authors, Jennifer M Meyer, Craig J Rouskey, Thanh-Long M Nguyen, Hideo Yagita, Philip D Greenberg, Richard J DiPaolo, Ryan M Teague. less Cancer Res, 2012 Nov 29; 73(2). PMID: 23188506 Free PMC article.
|
Potential uses of interleukin 2 in cancer therapy. M A Cheever, J A Thompson, D J Peace, P D Greenberg. Immunobiology, 1986 Sep 01; 172(3-5). PMID: 3492434
|
PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model. Long Zhang, Thomas F Gajewski, Justin Kline. Blood, 2009 May 07; 114(8). PMID: 19417208 Free PMC article. Highly Cited.
|
Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function. Jessica Ann Hernandez-Chacon, Yufeng Li, +5 authors, Richard C Wu, Chantale Bernatchez, Yijun Wang, Jeffrey S Weber, Patrick Hwu, Laszlo G Radvanyi. less J Immunother, 2011 Mar 11; 34(3). PMID: 21389874 Free PMC article.
|
Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors. Ryan M Teague, Blythe D Sather, +8 authors, Jilian A Sacks, Maria Z Huang, Michelle L Dossett, Junko Morimoto, Xiaoxio Tan, Susan E Sutton, Michael P Cooke, Claes Ohlén, Philip D Greenberg. less Nat Med, 2006 Feb 14; 12(3). PMID: 16474399
|
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'. Aron M Levin, Darren L Bates, +11 authors, Aaron M Ring, Carsten Krieg, Jack T Lin, Leon Su, Ignacio Moraga, Miro E Raeber, Gregory R Bowman, Paul Novick, Vijay S Pande, C Garrison Fathman, Onur Boyman, K Christopher Garcia. less Nature, 2012 Mar 27; 484(7395). PMID: 22446627 Free PMC article. Highly Cited.
|
Development of a Listeria monocytogenes based vaccine against prostate cancer. Vafa Shahabi, Mariela Reyes-Reyes, +3 authors, Anu Wallecha, Sandra Rivera, Yvonne Paterson, Paulo Maciag. less Cancer Immunol Immunother, 2008 Feb 15; 57(9). PMID: 18273616
|
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning. Hollie J Pegram, James C Lee, +4 authors, Erik G Hayman, Gavin H Imperato, Thomas F Tedder, Michel Sadelain, Renier J Brentjens. less Blood, 2012 Feb 23; 119(18). PMID: 22354001 Free PMC article. Highly Cited.
|
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Tyler J Curiel, George Coukos, +18 authors, Linhua Zou, Xavier Alvarez, Pui Cheng, Peter Mottram, Melina Evdemon-Hogan, Jose R Conejo-Garcia, Lin Zhang, Matthew Burow, Yun Zhu, Shuang Wei, Ilona Kryczek, Ben Daniel, Alan Gordon, Leann Myers, Andrew Lackner, Mary L Disis, Keith L Knutson, Lieping Chen, Weiping Zou. less Nat Med, 2004 Aug 24; 10(9). PMID: 15322536 Highly Cited.
|
High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings. M T Lotze, A E Chang, +3 authors, C A Seipp, C Simpson, J T Vetto, S A Rosenberg. less JAMA, 1986 Dec 12; 256(22). PMID: 3491225 Highly Cited.
|
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. P P Lee, C Yee, +9 authors, P A Savage, L Fong, D Brockstedt, J S Weber, D Johnson, S Swetter, J Thompson, P D Greenberg, M Roederer, M M Davis. less Nat Med, 1999 Jun 17; 5(6). PMID: 10371507 Highly Cited.
|
Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody. Robert H Vonderheide, Keith T Flaherty, +12 authors, Magi Khalil, Molly S Stumacher, David L Bajor, Natalie A Hutnick, Patricia Sullivan, J Joseph Mahany, Maryann Gallagher, Amy Kramer, Stephanie J Green, Peter J O'Dwyer, Kelli L Running, Richard D Huhn, Scott J Antonia. less J Clin Oncol, 2007 Mar 01; 25(7). PMID: 17327609 Highly Cited.
|
Cytosolic entry controls CD8+-T-cell potency during bacterial infection. Keith S Bahjat, Weiqun Liu, +4 authors, Edward E Lemmens, Stephen P Schoenberger, Daniel A Portnoy, Thomas W Dubensky, Dirk G Brockstedt. less Infect Immun, 2006 Sep 07; 74(11). PMID: 16954391 Free PMC article.
|
CAR T cells transform to trucks: chimeric antigen receptor-redirected T cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancer. Markus Chmielewski, Hinrich Abken. Cancer Immunol Immunother, 2012 Jan 26; 61(8). PMID: 22274776 Review.
|
Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer. Nicholas C Souders, Duane A Sewell, +4 authors, Zhen-Kun Pan, S Farzana Hussain, Alexander Rodriguez, Anu Wallecha, Yvonne Paterson. less Cancer Immun, 2007 Feb 07; 7. PMID: 17279610 Free PMC article.
|
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction. Dung T Le, Dirk G Brockstedt, +19 authors, Ran Nir-Paz, Johannes Hampl, Shruti Mathur, John Nemunaitis, Daniel H Sterman, Raffit Hassan, Eric Lutz, Bentley Moyer, Martin Giedlin, Jana-Lynn Louis, Elizabeth A Sugar, Alice Pons, Andrea L Cox, Jordana Levine, Aimee Luck Murphy, Peter Illei, Thomas W Dubensky, Joseph E Eiden, Elizabeth M Jaffee, Daniel A Laheru. less Clin Cancer Res, 2011 Dec 08; 18(3). PMID: 22147941 Free PMC article. Highly Cited.
|
Basic principles of tumor-associated regulatory T cell biology. Peter A Savage, Sven Malchow, Daniel S Leventhal. Trends Immunol, 2012 Sep 25; 34(1). PMID: 22999714 Free PMC article. Review.
|
New insights into the regulation of T cells by gamma(c) family cytokines. Yrina Rochman, Rosanne Spolski, Warren J Leonard. Nat Rev Immunol, 2009 Jun 23; 9(7). PMID: 19543225 Free PMC article. Highly Cited. Review.
|
Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Onur Boyman, Marek Kovar, +2 authors, Mark P Rubinstein, Charles D Surh, Jonathan Sprent. less Science, 2006 Feb 18; 311(5769). PMID: 16484453 Highly Cited.
|
Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers. J T Vetto, S Lum, +4 authors, A Morris, M Sicotte, J Davis, M Lemon, A Weinberg. less Am J Surg, 1997 Oct 27; 174(3). PMID: 9324133
|
Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia. John C Byrd, Thomas J Kipps, +8 authors, Ian W Flinn, Maureen Cooper, Olatoyosi Odenike, Jennifer Bendiske, John Rediske, Sanela Bilic, Jyotirmoy Dey, Johan Baeck, Susan O'Brien. less Leuk Lymphoma, 2012 Apr 06; 53(11). PMID: 22475052 Free PMC article.
|
Raising the bar: the curative potential of human cancer immunotherapy. Steven A Rosenberg. Sci Transl Med, 2012 Mar 31; 4(127). PMID: 22461638 Free PMC article. Highly Cited. Review.
|
T cell receptor gene therapy for cancer. Thomas M Schmitt, Gunnar B Ragnarsson, Philip D Greenberg. Hum Gene Ther, 2009 Aug 26; 20(11). PMID: 19702439 Free PMC article. Review.
|
CTLA-4: new insights into its biological function and use in tumor immunotherapy. Jackson G Egen, Michael S Kuhns, James P Allison. Nat Immunol, 2002 Jun 28; 3(7). PMID: 12087419 Highly Cited. Review.
|
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Haidong Dong, Scott E Strome, +10 authors, Diva R Salomao, Hideto Tamura, Fumiya Hirano, Dallas B Flies, Patrick C Roche, Jun Lu, Gefeng Zhu, Koji Tamada, Vanda A Lennon, Esteban Celis, Lieping Chen. less Nat Med, 2002 Jul 02; 8(8). PMID: 12091876 Highly Cited.
|
IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization. Kai-ping Han, Xiaoyun Zhu, +9 authors, Bai Liu, Emily Jeng, Lin Kong, Jason L Yovandich, Vinay V Vyas, Warren D Marcus, Pierre-Andre Chavaillaz, Christian A Romero, Peter R Rhode, Hing C Wong. less Cytokine, 2011 Oct 25; 56(3). PMID: 22019703 Free PMC article.
|
Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. A W Goldrath, L Y Bogatzki, M J Bevan. J Exp Med, 2000 Aug 22; 192(4). PMID: 10952725 Free PMC article. Highly Cited.
|
Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J Hernandez, S Aung, W L Redmond, L A Sherman. J Exp Med, 2001 Sep 19; 194(6). PMID: 11560988 Free PMC article.
|
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix. Paulo Cesar Maciag, Sinisa Radulovic, John Rothman. Vaccine, 2009 Apr 25; 27(30). PMID: 19389451 Highly Cited.
|
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40. E M Sotomayor, I Borrello, +6 authors, E Tubb, F M Rattis, H Bien, Z Lu, S Fein, S Schoenberger, H I Levitsky. less Nat Med, 1999 Jul 08; 5(7). PMID: 10395323 Highly Cited.
|
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Steven A Rosenberg, James C Yang, +12 authors, Richard M Sherry, Udai S Kammula, Marybeth S Hughes, Giao Q Phan, Deborah E Citrin, Nicholas P Restifo, Paul F Robbins, John R Wunderlich, Kathleen E Morton, Carolyn M Laurencot, Seth M Steinberg, Donald E White, Mark E Dudley. less Clin Cancer Res, 2011 Apr 19; 17(13). PMID: 21498393 Free PMC article. Highly Cited.
|
Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial. Renier Brentjens, Raymond Yeh, +2 authors, Yvette Bernal, Isabelle Riviere, Michel Sadelain. less Mol Ther, 2010 Apr 02; 18(4). PMID: 20357779 Free PMC article. Highly Cited.
|
OX40 is a potent immune-stimulating target in late-stage cancer patients. Brendan D Curti, Magdalena Kovacsovics-Bankowski, +20 authors, Nicholas Morris, Edwin Walker, Lana Chisholm, Kevin Floyd, Joshua Walker, Iliana Gonzalez, Tanisha Meeuwsen, Bernard A Fox, Tarsem Moudgil, William Miller, Daniel Haley, Todd Coffey, Brenda Fisher, Laurie Delanty-Miller, Nicole Rymarchyk, Tracy Kelly, Todd Crocenzi, Eric Bernstein, Rachel Sanborn, Walter J Urba, Andrew D Weinberg. less Cancer Res, 2013 Nov 02; 73(24). PMID: 24177180 Free PMC article. Highly Cited.
|
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. M T Lotze, Y L Matory, +5 authors, S E Ettinghausen, A A Rayner, S O Sharrow, C A Seipp, M C Custer, S A Rosenberg. less J Immunol, 1985 Oct 01; 135(4). PMID: 2993418 Highly Cited.
|
4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. W W Shuford, K Klussman, +11 authors, D D Tritchler, D T Loo, J Chalupny, A W Siadak, T J Brown, J Emswiler, H Raecho, C P Larsen, T C Pearson, J A Ledbetter, A Aruffo, R S Mittler. less J Exp Med, 1997 Jul 07; 186(1). PMID: 9206996 Free PMC article. Highly Cited.
|
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. I Melero, W W Shuford, +5 authors, S A Newby, A Aruffo, J A Ledbetter, K E Hellström, R S Mittler, L Chen. less Nat Med, 1997 Jun 01; 3(6). PMID: 9176498 Highly Cited.
|
Nivolumab plus ipilimumab in advanced melanoma. Jedd D Wolchok, Harriet Kluger, +21 authors, Margaret K Callahan, Michael A Postow, Naiyer A Rizvi, Alexander M Lesokhin, Neil H Segal, Charlotte E Ariyan, Ruth-Ann Gordon, Kathleen Reed, Matthew M Burke, Anne Caldwell, Stephanie A Kronenberg, Blessing U Agunwamba, Xiaoling Zhang, Israel Lowy, Hector David Inzunza, William Feely, Christine E Horak, Quan Hong, Alan J Korman, Jon M Wigginton, Ashok Gupta, Mario Sznol. less N Engl J Med, 2013 Jun 04; 369(2). PMID: 23724867 Free PMC article. Highly Cited.
|
Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection. Thomas M Schmitt, David H Aggen, +4 authors, Ingunn M Stromnes, Michelle L Dossett, Sarah A Richman, David M Kranz, Philip D Greenberg. less Blood, 2013 May 16; 122(3). PMID: 23673862 Free PMC article.
|
Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myeloma. Wenxin Xu, Monica Jones, +10 authors, Bai Liu, Xiaoyun Zhu, Christopher B Johnson, Ana C Edwards, Lin Kong, Emily K Jeng, Kaiping Han, Warren D Marcus, Mark P Rubinstein, Peter R Rhode, Hing C Wong. less Cancer Res, 2013 May 07; 73(10). PMID: 23644531 Free PMC article. Highly Cited.
|
Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. G R Gunn, A Zubair, +3 authors, C Peters, Z K Pan, T C Wu, Y Paterson. less J Immunol, 2001 Nov 21; 167(11). PMID: 11714814
|
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. Tyler R Simpson, Fubin Li, +11 authors, Welby Montalvo-Ortiz, Manuel A Sepulveda, Katharina Bergerhoff, Frederick Arce, Claire Roddie, Jake Y Henry, Hideo Yagita, Jedd D Wolchok, Karl S Peggs, Jeffrey V Ravetch, James P Allison, Sergio A Quezada. less J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981 Free PMC article. Highly Cited.
|
Harnessing human dendritic cell subsets for medicine. Hideki Ueno, Nathalie Schmitt, +8 authors, Eynav Klechevsky, Alexander Pedroza-Gonzalez, Toshimichi Matsui, Gerard Zurawski, SangKon Oh, Joseph Fay, Virginia Pascual, Jacques Banchereau, Karolina Palucka. less Immunol Rev, 2010 Mar 03; 234(1). PMID: 20193020 Free PMC article. Review.
|
Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells. Joseph F Grosso, Monica V Goldberg, +7 authors, Derese Getnet, Tullia C Bruno, Hung-Rong Yen, Kristin J Pyle, Edward Hipkiss, Dario A A Vignali, Drew M Pardoll, Charles G Drake. less J Immunol, 2009 May 21; 182(11). PMID: 19454660 Free PMC article.
|
The blockade of immune checkpoints in cancer immunotherapy. Drew M Pardoll. Nat Rev Cancer, 2012 Mar 23; 12(4). PMID: 22437870 Free PMC article. Highly Cited. Review.
|
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. B Almand, J I Clark, +5 authors, E Nikitina, J van Beynen, N R English, S C Knight, D P Carbone, D I Gabrilovich. less J Immunol, 2000 Dec 21; 166(1). PMID: 11123353 Highly Cited.
|
Management of immune-related adverse events and kinetics of response with ipilimumab. Jeffrey S Weber, Katharina C Kähler, Axel Hauschild. J Clin Oncol, 2012 May 23; 30(21). PMID: 22614989 Highly Cited. Review.
|
Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma. Markus Chmielewski, Andreas A Hombach, Hinrich Abken. Immunol Rev, 2013 Dec 18; 257(1). PMID: 24329791 Review.
|
Sipuleucel-T immunotherapy for castration-resistant prostate cancer. Philip W Kantoff, Celestia S Higano, +11 authors, Neal D Shore, E Roy Berger, Eric J Small, David F Penson, Charles H Redfern, Anna C Ferrari, Robert Dreicer, Robert B Sims, Yi Xu, Mark W Frohlich, Paul F Schellhammer, IMPACT Study Investigators. less N Engl J Med, 2010 Sep 08; 363(5). PMID: 20818862 Highly Cited.
|
Immune evasion in acute myeloid leukemia: current concepts and future directions. Ryan M Teague, Justin Kline. J Immunother Cancer, 2013 Dec 20; 1(13). PMID: 24353898 Free PMC article.
|
Cancer regression in patients after transfer of genetically engineered lymphocytes. Richard A Morgan, Mark E Dudley, +13 authors, John R Wunderlich, Marybeth S Hughes, James C Yang, Richard M Sherry, Richard E Royal, Suzanne L Topalian, Udai S Kammula, Nicholas P Restifo, Zhili Zheng, Azam Nahvi, Christiaan R de Vries, Linda J Rogers-Freezer, Sharon A Mavroukakis, Steven A Rosenberg. less Science, 2006 Sep 02; 314(5796). PMID: 16946036 Free PMC article. Highly Cited.
|
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. Richard A Morgan, Nachimuthu Chinnasamy, +28 authors, Daniel Abate-Daga, Alena Gros, Paul F Robbins, Zhili Zheng, Mark E Dudley, Steven A Feldman, James C Yang, Richard M Sherry, Giao Q Phan, Marybeth S Hughes, Udai S Kammula, Akemi D Miller, Crystal J Hessman, Ashley A Stewart, Nicholas P Restifo, Martha M Quezado, Meghna Alimchandani, Avi Z Rosenberg, Avindra Nath, Tongguang Wang, Bibiana Bielekova, Simone C Wuest, Nirmala Akula, Francis J McMahon, Susanne Wilde, Barbara Mosetter, Dolores J Schendel, Carolyn M Laurencot, Steven A Rosenberg. less J Immunother, 2013 Feb 05; 36(2). PMID: 23377668 Free PMC article. Highly Cited.
|
Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. Ryan A Wilcox, Dallas B Flies, +6 authors, Gefeng Zhu, Aaron J Johnson, Koji Tamada, Andrei I Chapoval, Scott E Strome, Larry R Pease, Lieping Chen. less J Clin Invest, 2002 Mar 06; 109(5). PMID: 11877473 Free PMC article.
|
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Arlene H Sharpe, E John Wherry, Rafi Ahmed, Gordon J Freeman. Nat Immunol, 2007 Feb 17; 8(3). PMID: 17304234 Highly Cited. Review.
|
IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression. Markus Chmielewski, Caroline Kopecky, Andreas A Hombach, Hinrich Abken. Cancer Res, 2011 Jul 12; 71(17). PMID: 21742772 Highly Cited.
|
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Christian S Hinrichs, Rosanne Spolski, +7 authors, Chrystal M Paulos, Luca Gattinoni, Keith W Kerstann, Douglas C Palmer, Christopher A Klebanoff, Steven A Rosenberg, Warren J Leonard, Nicholas P Restifo. less Blood, 2008 Feb 16; 111(11). PMID: 18276844 Free PMC article. Highly Cited.
|
Selective in vitro growth of T lymphocytes from normal human bone marrows. D A Morgan, F W Ruscetti, R Gallo. Science, 1976 Sep 10; 193(4257). PMID: 181845 Highly Cited.
|
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. Gerald P Linette, Edward A Stadtmauer, +20 authors, Marcela V Maus, Aaron P Rapoport, Bruce L Levine, Lyndsey Emery, Leslie Litzky, Adam Bagg, Beatriz M Carreno, Patrick J Cimino, Gwendolyn K Binder-Scholl, Dominic P Smethurst, Andrew B Gerry, Nick J Pumphrey, Alan D Bennett, Joanna E Brewer, Joseph Dukes, Jane Harper, Helen K Tayton-Martin, Bent K Jakobsen, Namir J Hassan, Michael Kalos, Carl H June. less Blood, 2013 Jun 19; 122(6). PMID: 23770775 Free PMC article. Highly Cited.
|
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. Kaori Sakuishi, Lionel Apetoh, +3 authors, Jenna M Sullivan, Bruce R Blazar, Vijay K Kuchroo, Ana C Anderson. less J Exp Med, 2010 Sep 08; 207(10). PMID: 20819927 Free PMC article. Highly Cited.
|
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. R R French, H T Chan, A L Tutt, M J Glennie. Nat Med, 1999 May 06; 5(5). PMID: 10229232 Highly Cited.
|
Re-adapting T cells for cancer therapy: from mouse models to clinical trials. Ingunn M Stromnes, Thomas M Schmitt, +2 authors, Aude G Chapuis, Sunil R Hingorani, Philip D Greenberg. less Immunol Rev, 2013 Dec 18; 257(1). PMID: 24329795 Free PMC article. Review.
|
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. Rong Zeng, Rosanne Spolski, +9 authors, Steven E Finkelstein, SangKon Oh, Panu E Kovanen, Christian S Hinrichs, Cynthia A Pise-Masison, Michael F Radonovich, John N Brady, Nicholas P Restifo, Jay A Berzofsky, Warren J Leonard. less J Exp Med, 2005 Jan 05; 201(1). PMID: 15630141 Free PMC article. Highly Cited.
|
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. D Hawiger, K Inaba, +6 authors, Y Dorsett, M Guo, K Mahnke, M Rivera, J V Ravetch, R M Steinman, M C Nussenzweig. less J Exp Med, 2001 Sep 19; 194(6). PMID: 11560993 Free PMC article. Highly Cited.
|
Interleukin-21: basic biology and implications for cancer and autoimmunity. Rosanne Spolski, Warren J Leonard. Annu Rev Immunol, 2007 Oct 24; 26. PMID: 17953510 Highly Cited. Review.
|
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Omar S Qureshi, Yong Zheng, +12 authors, Kyoko Nakamura, Kesley Attridge, Claire Manzotti, Emily M Schmidt, Jennifer Baker, Louisa E Jeffery, Satdip Kaur, Zoe Briggs, Tie Z Hou, Clare E Futter, Graham Anderson, Lucy S K Walker, David M Sansom. less Science, 2011 Apr 09; 332(6029). PMID: 21474713 Free PMC article. Highly Cited.
|
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. T Takahashi, T Tagami, +5 authors, S Yamazaki, T Uede, J Shimizu, N Sakaguchi, T W Mak, S Sakaguchi. less J Exp Med, 2000 Jul 19; 192(2). PMID: 10899917 Free PMC article. Highly Cited.
|
Studies on the immunological response to foreign tumor transplants in the mouse. I. The role of lymph node cells in conferring immunity by adoptive transfer. N A MITCHISON. J Exp Med, 1955 Aug 01; 102(2). PMID: 13242741 Free PMC article. Highly Cited.
|
OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor. Michael J Gough, Carl E Ruby, +3 authors, William L Redmond, Birat Dhungel, Alexis Brown, Andrew D Weinberg. less Cancer Res, 2008 Jul 03; 68(13). PMID: 18593921
|
Mitigating the toxic effects of anticancer immunotherapy. Tara C Gangadhar, Robert H Vonderheide. Nat Rev Clin Oncol, 2014 Jan 22; 11(2). PMID: 24445516 Highly Cited. Review.
|
Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Wei Liao, Jian-Xin Lin, Warren J Leonard. Immunity, 2013 Jan 29; 38(1). PMID: 23352221 Free PMC article. Highly Cited. Review.
|
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. Stephan A Grupp, Michael Kalos, +10 authors, David Barrett, Richard Aplenc, David L Porter, Susan R Rheingold, David T Teachey, Anne Chew, Bernd Hauck, J Fraser Wright, Michael C Milone, Bruce L Levine, Carl H June. less N Engl J Med, 2013 Mar 27; 368(16). PMID: 23527958 Free PMC article. Highly Cited.
|
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Suzanne Ostrand-Rosenberg. Cancer Immunol Immunother, 2010 Apr 24; 59(10). PMID: 20414655 Free PMC article. Highly Cited. Review.
|
Molecular basis of T cell inactivation by CTLA-4. K M Lee, E Chuang, +7 authors, M Griffin, R Khattri, D K Hong, W Zhang, D Straus, L E Samelson, C B Thompson, J A Bluestone. less Science, 1998 Dec 18; 282(5397). PMID: 9856951 Highly Cited.
|
OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. P R Rogers, J Song, +2 authors, I Gramaglia, N Killeen, M Croft. less Immunity, 2001 Sep 25; 15(3). PMID: 11567634 Highly Cited.
|
Combination checkpoint blockade--taking melanoma immunotherapy to the next level. James L Riley. N Engl J Med, 2013 Jun 04; 369(2). PMID: 23724866
|
Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Alberto Sánchez-Fueyo, Jane Tian, +10 authors, Dominic Picarella, Christoph Domenig, Xin Xiao Zheng, Catherine A Sabatos, Natasha Manlongat, Orissa Bender, Thomas Kamradt, Vijay K Kuchroo, José-Carlos Gutiérrez-Ramos, Anthony J Coyle, Terry B Strom. less Nat Immunol, 2003 Oct 14; 4(11). PMID: 14556005 Highly Cited.
|
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. Omid Hamid, Caroline Robert, +23 authors, Adil Daud, F Stephen Hodi, Wen-Jen Hwu, Richard Kefford, Jedd D Wolchok, Peter Hersey, Richard W Joseph, Jeffrey S Weber, Roxana Dronca, Tara C Gangadhar, Amita Patnaik, Hassane Zarour, Anthony M Joshua, Kevin Gergich, Jeroen Elassaiss-Schaap, Alain Algazi, Christine Mateus, Peter Boasberg, Paul C Tumeh, Bartosz Chmielowski, Scot W Ebbinghaus, Xiaoyun Nicole Li, S Peter Kang, Antoni Ribas. less N Engl J Med, 2013 Jun 04; 369(2). PMID: 23724846 Free PMC article. Highly Cited.
|
TNF/TNFR family members in costimulation of T cell responses. Tania H Watts. Annu Rev Immunol, 2005 Mar 18; 23. PMID: 15771565 Highly Cited. Review.
|
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. S A Rosenberg, J C Yang, +13 authors, D J Schwartzentruber, P Hwu, F M Marincola, S L Topalian, N P Restifo, M E Dudley, S L Schwarz, P J Spiess, J R Wunderlich, M R Parkhurst, Y Kawakami, C A Seipp, J H Einhorn, D E White. less Nat Med, 1998 Mar 21; 4(3). PMID: 9500606 Free PMC article. Highly Cited.
|
The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. J P Siegel, M Sharon, P L Smith, W J Leonard. Science, 1987 Oct 02; 238(4823). PMID: 3116668 Highly Cited.
|
Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates. G Jung, J A Ledbetter, H J Müller-Eberhard. Proc Natl Acad Sci U S A, 1987 Jul 01; 84(13). PMID: 3110771 Free PMC article.
|
CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases. Christine Guntermann, Denis R Alexander. J Immunol, 2002 Apr 24; 168(9). PMID: 11970985
|